A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome

Sleep Medicine

Volumn 12, Issue 5, 2011, Pages 440-444

  Silver, Nathan ^a   Allen, Richard P ^b   Senerth, Julia ^a   Earley, Christopher J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine agonist; Long term follow up; Methadone; Opioid; Pergolide; Pramipexole; Restless legs augmentation; Restless legs syndrome

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; METHADONE; OPIATE; PERGOLIDE; PRAMIPEXOLE;

ANXIETY; ARTICLE; AUGMENTATION; CONSCIOUSNESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; INSOMNIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NAUSEA; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION;

ANALGESICS, OPIOID; BENZOTHIAZOLES; CHRONIC DISEASE; DOPAMINE AGONISTS; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; METHADONE; PERGOLIDE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79955114643     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.11.002     Document Type: Article

References (21)

1. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19(3):205-213.
2. Trenkwalder C., Benes H., Poewe W., Oertel W.H., Garcia-Borreguero D., de Weerd A.W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7(7):595-604.
3. Partinen M., Hirvonen K., Jama L., Alakuijala A., Hublin C., Tamminen I., et al. Open-label study of the long-term efficacy and safety of pramipexole in patients with restless legs syndrome (extension of the PRELUDE study). Sleep Med 2008, 9(5):537-541.
4. Oertel W.H., Stiasny-Kolster K., Bergtholdt B., Hallstrom Y., Albo J., Leissner L., et al. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord 2007, 22(2):213-219.
5. Montplaisir J., Karrasch J., Haan J., Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 2006, 21(10):1627-1635.
6. Montplaisir J., Fantini M.L., Desautels A., Michaud M., Petit D., Filipini D. Long-term treatment with pramipexole in restless legs syndrome. Eur J Neurol 2006, 13(12):1306-1311.
7. Garcia-Borreguero D., Grunstein R., Sridhar G., Dreykluft T., Montagna P., Dom R., et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med 2007, 8(7-8):742-752.
8. Trenkwalder C., Garcia-Borreguero D., Montagna P., Lainey E., De Weerd A.W., Tidswell P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004, 75(1):92-97.
9. Trenkwalder C., Hundemer H.P., Lledo A., Swieca J., Polo O., Wetter T.C., et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 2004, 62(8):1391-1397.
10. Walters A.S., Ondo W.G., Dreykluft T., Grunstein R., Lee D., Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004, 19(12):1414-1423.
11. Earley C.J., Allen R.P. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996, 19:801-810.
12. Silber M.H., Girish M., Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 2003, 26(7):819-821.
13. Winkelman J.W., Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 2004, 5(1):9-14.
14. Hening W., Allen R., Earley C., Kushida C., Picchietti D., Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999, 22(7):970-999.
15. Vetrugno R., La Morgia C., D'Angelo R., Loi D., Provini F., Plazzi G., et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord 2007, 22(3):424-427.
16. Earley C.J., Allen R.P. Restless legs syndrome augmentation associated with tramadol. Sleep Med 2006, 7(7):592-593.
17. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4(2):101-119.
18. Allen R.P., Earley C.J. An open label clinical trial with structured subjective reports and objective leg activity measures comparing gabapentin with alternative treatment in the restless legs syndrome. Sleep Res 1996, 25:184.
19. Ondo W.G. Methadone for refractory restless legs syndrome. Mov Disord 2005, 20(3):345-348.
20. Hening W.A., Allen R.P., Ondo W.G., Walters A.S., Winkelman J.W., Becker P., et al. Schollmayer E; SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled tiral in the United States. Mov Disord 2010, 25(11):1675-1683.
21. Allen R.P., Walters A.S., Montplaisir J., Hening W., Myers A., Bell T.J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165(11):1286-1292.